Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Search Results 1-10 of 57 for Tumor+suppressor+gene
PTEN is one of the most frequently mutated or deleted tumor suppressor genes in prostate cancer.
Pten is the most prominent human tumor suppressor after p53.
MEDIA CONTACT: Robert Nellis, Mayo Clinic Public Affairs, 507-284-5005, email@example.com #Cancer #CHANGE #Chromosomes #Jan van Deursen #Mayo Clinic #Minnesota News Releases #Mitosis #Nature Cell Biology #News Releases #P53 #Research #Rochester #...
However, Mayo investigators identified that an uncommon type of an aggressive breast cancer, the luminal androgen receptor subtype of triple negative breast cancer (TNBC), was less likely to respond to chemotherapy, and was more likely to contain a u...
The finding suggests that the gene has an important tumor suppressor-like function and that insufficient function can promote lung cancer development.
Normally, this gene produces a tumor suppressor protein that helps control the growth of Schwann cells covering the nerves.
"The altered microRNA might target tumor suppressor genes, it might activate a cancer gene, it might be involved in regulating the stability of the genome, or there might be somethin...
FOXO3a is known as a suppressor of tumor growth because it responds to all forms of cell stress, including that produced in cancer, by turning on genes inside the nucleus that trigger the cell's deat...
"But that may be because many of the patients likely had a mutation in the TRP53 tumor suppressor, so erlotinib would not help them, since EGFR was no longer necessary for tumor growth.
The lab has: Identified RhoB as a key modulator for drug response Described a paradigm shift for the tumor suppressor FoxO3a, whereby the research team identified a new oncogenic role promoting tumor...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.